DE69018357D1 - Mutein von HST-1 und seine Herstellung. - Google Patents

Mutein von HST-1 und seine Herstellung.

Info

Publication number
DE69018357D1
DE69018357D1 DE69018357T DE69018357T DE69018357D1 DE 69018357 D1 DE69018357 D1 DE 69018357D1 DE 69018357 T DE69018357 T DE 69018357T DE 69018357 T DE69018357 T DE 69018357T DE 69018357 D1 DE69018357 D1 DE 69018357D1
Authority
DE
Germany
Prior art keywords
mutein
hst
production
wounds
heparin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69018357T
Other languages
English (en)
Other versions
DE69018357T2 (de
Inventor
Masaaki Terada
Hiromi Sakamoto
Teruhiko Yoshida
Koichi Igarashi
Yoshio Kozai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
National Cancer Center Japan
Original Assignee
National Cancer Center Japan
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Cancer Center Japan, Takeda Chemical Industries Ltd filed Critical National Cancer Center Japan
Application granted granted Critical
Publication of DE69018357D1 publication Critical patent/DE69018357D1/de
Publication of DE69018357T2 publication Critical patent/DE69018357T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Transducers For Ultrasonic Waves (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69018357T 1989-10-06 1990-10-05 Mutein von HST-1 und seine Herstellung. Expired - Fee Related DE69018357T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26233189 1989-10-06
JP27303689 1989-10-19
JP30360789 1989-11-21

Publications (2)

Publication Number Publication Date
DE69018357D1 true DE69018357D1 (de) 1995-05-11
DE69018357T2 DE69018357T2 (de) 1995-09-21

Family

ID=27335120

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69018357T Expired - Fee Related DE69018357T2 (de) 1989-10-06 1990-10-05 Mutein von HST-1 und seine Herstellung.

Country Status (5)

Country Link
US (1) US5639862A (de)
EP (1) EP0421455B1 (de)
AT (1) ATE120799T1 (de)
CA (1) CA2027075C (de)
DE (1) DE69018357T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459250A (en) * 1987-06-16 1995-10-17 New York University Truncated mammalian growth factor DNA sequence
EP0499242B1 (de) * 1991-02-15 1996-06-26 Takeda Chemical Industries, Ltd. Mit einem Zellwachstumsfaktor bewirkte Anregung von Wachstum im Knocheninneren
EP0585631A1 (de) * 1992-08-05 1994-03-09 Takeda Chemical Industries, Ltd. Blutplättchen vermehrendes Agens
ATE241698T1 (de) * 1993-02-12 2003-06-15 Takeda Chemical Industries Ltd Hst-2 mutein, dafür kodierende dns und herstellung
MXPA00010110A (es) * 1998-04-17 2002-08-06 Angiogenix Inc Factores angiogenicos terapeuticos y metodos para su uso.
JP2002527401A (ja) * 1998-10-13 2002-08-27 カイロン コーポレイション Ｆｇｆの脈管形成的に有効な単位用量および投与方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0326907A1 (de) * 1988-01-26 1989-08-09 Takeda Chemical Industries, Ltd. Polypeptide, DNA und ihre Verwendung

Also Published As

Publication number Publication date
US5639862A (en) 1997-06-17
CA2027075A1 (en) 1991-04-07
DE69018357T2 (de) 1995-09-21
CA2027075C (en) 2002-11-26
EP0421455A1 (de) 1991-04-10
ATE120799T1 (de) 1995-04-15
EP0421455B1 (de) 1995-04-05

Similar Documents

Publication Publication Date Title
KR960013574B1 (en) Basic fibroblast growth factor mutein, and its coding dna
DE3674906D1 (de) Selbstklemmende medizinische prothese und ihre herstellung.
ATE79545T1 (de) Verwendung vom ''cartilage-inducing faktor b(cif- b)'' zur herstellung eines arzneimittels gegen das wachstum von tumoren.
DE68918331D1 (de) Menschlicher kristallinischer Granulocyt-Koloniestimulierungsfaktor und dessen Herstellung.
ATE97813T1 (de) Mittel zur kontrolle von thrombenbildungen.
DE69018357D1 (de) Mutein von HST-1 und seine Herstellung.
CA2096520A1 (en) Therapeutic agent for skin or corneal disease
BG60324B2 (en) New somatotropines
ATE79254T1 (de) Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
CA2011008A1 (en) Egf variants and pharmaceutical use thereof
DE68909254D1 (de) Heparinbindende Gehirnmitogene.
DE69016284D1 (de) Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
ES2094757T3 (es) Un factor megacariocitopoyetico.
DK495187A (da) Fremgangsmaade til fremme af saarheling
ATE86105T1 (de) Verwendung von probucol zur herstellung eines arzneimittels fuer die behandlung von herzarrhythmie.
NO890261D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridin-derivater.
ATE84418T1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
UA8421A1 (uk) Препарат для лікування опіків, трофічних язв та раневих пошкоджень шкіри віватон-2

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAKEDA PHARMACEUTICAL CO. LTD., OSAKA, JP

Owner name: PRESIDENT OF NATIONAL CANCER CENTER, TOKIO/TOKYO,

8339 Ceased/non-payment of the annual fee